SAB Biotherapeutics, Inc.SABSNASDAQ
Loading
Year-over-year net income growth rate
Latest
-137.10%
↓ 160% vs avg
Percentile
P20
Within normal range
Streak
1 qtr
Consecutive declineDecelerating
Average
-52.67%
Historical baseline
| Period | Value |
|---|---|
| Q4 2025 | -137.10% |
| Q3 2025 | 549.32% |
| Q2 2025 | -94.63% |
| Q1 2025 | 54.39% |
| Q4 2024 | -10.10% |
| Q3 2024 | -41.09% |
| Q2 2024 | -45.96% |
| Q1 2024 | 78.01% |
| Q4 2023 | -348.00% |
| Q3 2023 | 25.85% |
| Q2 2023 | 6.43% |
| Q1 2023 | 6.61% |
| Q4 2022 | -11.28% |
| Q3 2022 | -48.16% |
| Q2 2022 | -584.45% |
| Q1 2022 | 108.53% |
| Q4 2021 | -184.44% |
| Q3 2021 | -38.06% |
| Q2 2021 | -308.65% |
| Q1 2021 | -83.31% |
| Q4 2020 | 0.00% |